Views & Analysis Pharma R&D is crying out for disruption – is AI the answer? Artificial Intelligence (AI), big data and genomics are coming together to revolutionise drug discovery and development.
Views & Analysis Digital health round-up: Bupa latest health insurer to adopt... Richard Staines gives his weekly round-up of the biggest stories in digital health.
News AI-backed blood test could reduce reliance on cancer drugs Approach could reduce use of cancer drugs.
News Doctor's 'bedside manner' important in AI-dominated healthca... Physician's ‘bedside manner’ is likely to become increasingly important.
News Nearly half of life science professionals using AI - survey But lack of technical expertise holding back projects.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.